Respiratory Drug Closer to Approval
Theravance announced that a Food & Drug Administration panel voted in favor of approving its BREO Ellipta respiratory drug. THRX is up 15 percent before the bell on my tradeMONSTER platform.
Select Comfort Earnings, Revenue Miss
Select Comfort reported first-quarter earnings of $0.41 a share, missing the $0.43 average analyst estimate. Revenue of $258.2 million also missed the $288 million consensus number, and management cut full-year profit guidance. SCSS drops 3 percent in early trading.
Weak Sales Hurt eBay
EBay's earnings beat by a penny, but revenue was just $3.75 billion. Analysts had forecast $3.77 billion. Guidance was also lower than expected, and EBAY is down 3.5 percent in the premarket.
More From optionMONSTER
- Bears prepare for pullback in Masco
- Will Cash America's earnings pay off?
- Buyers chip into NXP before earnings
- Investment & Company Information